サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1579725

ウェアラブル注射器の世界市場

Wearable Injectors

出版日
ページ情報
英文 193 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.89円
ウェアラブル注射器の世界市場
出版日: 2024年10月30日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 193 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

ウェアラブル注射器の世界市場は2030年までに204億米ドルに達する見込み

2023年に107億米ドルと推定されるウェアラブル注射器の世界市場は、分析期間2023-2030年にCAGR 9.6%で成長し、2030年には204億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるオンボディインジェクターは、CAGR 9.4%を記録し、分析期間終了までに147億米ドルに達すると予測されます。オフボディインジェクターセグメントの成長率は、分析期間中CAGR 10.1%と推定されます。

米国市場は29億米ドル、中国はCAGR9.0%で成長すると予測

米国のウェアラブル注射器市場は2023年に29億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに32億米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは9.0%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ8.5％と8.0％と予測されています。欧州では、ドイツがCAGR約7.5%で成長すると予測されています。

世界のウェアラブル注射器市場- 主要動向と市場促進要因を探る

なぜウェアラブル注射器がドラッグデリバリーの分野に革命を起こすのか？

ウェアラブル注射器は、ドラッグデリバリーにおける画期的なイノベーションとして登場し、従来の注射法に代わる便利で患者に優しい代替手段を提供しています。しかし、ウェアラブル注射器の何が、現代のヘルスケアに変革をもたらすのでしょうか？ウェアラブル注射器は、コンパクトでユーザーフレンドリーなデバイスで、大量の薬剤を皮下投与するために設計されています。これらのデバイスは患者の体に装着され、手作業による注射を繰り返すことなく、継続的または定期的なドラッグデリバリーを可能にします。ウェアラブル注射器は、モノクローナル抗体、ホルモン、その他の副作用を避けるためにゆっくりと注入する必要がある高粘度製剤などの生物学的製剤の投与に特に有益です。患者にとって、より快適で侵襲の少ない選択肢を提供し、特に頻繁な投与が必要な慢性疾患の治療レジメンの遵守を容易にします。

ウェアラブル注射器の需要を牽引しているのは、糖尿病、自己免疫疾患、心血管疾患など、長期の投薬管理を必要とする慢性疾患の蔓延です。これらの疾患の多くでは、生物学的製剤が標準治療となっていますが、その複雑な投与が患者の服薬アドヒアランスの障害となっています。ウェアラブル注射器は、患者が家庭で薬を自己管理できるようにすることでこの課題に対処し、頻繁な通院の必要性を減らし、治療コンプライアンスを向上させます。さらに、ウェアラブル注射器は、化学療法や支持療法に使用される薬剤を、コントロールされた快適な方法で投与するために使用され、腫瘍学の分野でも人気を集めています。製薬業界がより多くの生物学的製剤を開発し続ける中、ウェアラブル注射器はこれらの複雑な薬剤の送達において、患者の転帰や生活の質を向上させるために、ますます重要な役割を果たすことが期待されています。

技術の進歩は、ウェアラブル注射器の性能をどのように高めていますか？

ウェアラブル注射器市場は、これらのデバイスの安全性、効率性、使いやすさを向上させる重要な技術的進歩を目の当たりにしてきました。しかし、これらの発展の原動力となっている主な技術革新とは何でしょうか？最も注目すべき進歩のひとつは、ウェアラブル注射器に電子技術やデジタル技術が統合され、投与量や投与速度を正確にコントロールできるようになったことです。最新のウェアラブル注射器には、マイクロプロセッサー制御のメカニズムが搭載されており、正確で安定したドラッグデリバリーを実現し、過少投与や過剰投与のリスクを最小限に抑えます。また、投与スケジュールをあらかじめプログラムしておくことで、複雑な治療レジメンにも柔軟に対応することができます。スマートセンサーと接続機能の統合により、ウェアラブル注射器は患者の服薬アドヒアランスを監視し、スマートフォンアプリや接続された健康プラットフォームを通じてリアルタイムでフィードバックを提供することができます。この接続性により、患者やヘルスケアプロバイダーは投与履歴を追跡し、デバイスの性能を監視し、注入プロセス中に問題が発生した場合にはアラートを受け取ることができます。

もう一つの重要な技術革新は、ウェアラブル注射器の快適性と使いやすさを向上させる高度な素材と人間工学に基づいたデザインの開発です。これらのデバイスは現在、軽量で生体適合性のある素材で作られており、身体の輪郭にフィットするため、長時間装着しても快適です。粘着技術の革新により、運動中でも皮膚に刺激を与えることなく、しっかりと装着できるようになりました。また、ウェアラブル注射器のデザインも進化し、簡単に操作できるボタン、視覚的・聴覚的インジケーター、針の自動挿入・引き込みシステムなど、控えめで使いやすい機能を備えています。これらの進歩により、ウェアラブル注射器を使用する際の複雑さが軽減され、手先の不自由な方や視力の弱い方など、より多くの患者さんが使用できるようになりました。さらに、自己注射トレーニングツールやバーチャルシミュレーションの開発により、これらのデバイスを使用する際の患者の自信や習熟度が向上し、アドヒアランス率の向上や治療成績の改善に寄与しています。

ヘルスケアにおけるウェアラブル注射器の普及を促進する市場動向とは？

患者、医療従事者、製薬会社のニーズや嗜好の進化を反映し、様々なヘルスケアシーンでウェアラブル注射器が採用されている背景には、いくつかの重要な市場動向があります。最も顕著な動向の一つは、患者中心のケアと治療の自己管理へのシフトです。個別化医療や在宅ヘルスケアへの注目が高まる中、ウェアラブル注射器は快適な自宅での治療管理を望む患者にとって好ましい選択肢となっています。この動向は、継続的なドラッグデリバリーや定期的な投与が必要とされる慢性疾患の管理において特に顕著です。ウェアラブル注射器は、頻繁に病院や診療所を訪れることなく、便利で、目立たず、信頼できる薬剤投与手段を患者に提供することで、患者に力を与えます。これにより、患者の利便性が向上するだけでなく、ヘルスケア施設の負担も軽減されるため、ウェアラブル注射器は資源利用の最適化を目指すヘルスケアシステムにとって魅力的な選択肢となります。

ウェアラブル注射器の採用を促進するもう一つの重要な動向は、生物学的製剤と高粘度薬剤の使用の増加です。様々な治療用タンパク質、抗体、ホルモンを含む生物学的製剤は、従来の注射器や自動注射器では容易に投与できない大量の薬剤が投与されることがよくあります。ウェアラブル注射器は、高粘度製剤を長期間にわたってコントロールしながらデリバリーできるようにすることで、これらの薬剤を投与するためのソリューションを提供します。これにより、自己投与が可能な治療の幅が広がり、より多くの患者が自宅で生物学的製剤による治療を受けられるようになりました。さらに、製薬会社はウェアラブル注射器メーカーと協力し、薬剤とデバイスを一体化したプレフィルド・ユニットのコンビネーション製品を開発する動きが加速しています。これらのコンビネーション製品はドラッグデリバリーのプロセスを簡素化し、患者の利便性を高め、投与ミスのリスクを低減し、ウェアラブル注射器のさらなる普及を促進します。生物製剤の市場が成長し続け、患者にやさしいドラッグデリバリーソリューションへのニーズが高まるにつれ、ウェアラブル注射器は多くの治療レジメンの標準的な構成要素になると予想されます。

世界のウェアラブル注射器市場の成長を促進する要因は？

世界のウェアラブル注射器市場の成長は、ドラッグデリバリー技術の進歩、慢性疾患の有病率の増加、在宅ヘルスケアの採用増加など、いくつかの要因によって牽引されています。主な成長要因のひとつは、自己免疫疾患、がん、ホルモン障害など幅広い疾患の治療に使用される生物学的製剤に対する需要の高まりです。生物学的製剤は、大量投与や長時間の点滴を必要とすることが多いため、ウェアラブル注射器を介したドラッグデリバリーに適しています。生物学的製剤のパイプラインの拡大と、これらの治療を受ける患者の増加により、これらの複雑な薬剤を安全かつ効果的に送達できるウェアラブル注射器には大きな市場機会が生まれています。製薬会社は、ドラッグデリバリー戦略の一環として、特に患者のアドヒアランスと長期管理が必要な治療薬にウェアラブル注射器を採用するようになってきています。

もう一つの重要な成長要因は、患者の服薬アドヒアランスと治療コンプライアンスを向上させることへの注目が高まっていることです。注射療法のアドヒアランス不良は慢性疾患管理における大きな課題であり、最適な治療結果やヘルスケアコストの増加につながります。ウェアラブル注射器は、より便利で侵襲性の低いドラッグデリバリー方法を提供することで、従来の注射に伴う頻度や不快感を軽減し、この課題に対処します。また、ウェアラブル注射器は長期間にわたって薬剤を投与することができるため、何度も注射をする必要がなくなり、患者が処方されたレジメンを守りやすくなります。ウェアラブル注射器のスマートテクノロジーと接続機能の統合により、リマインダーの提供、投与履歴のモニタリング、ヘルスケアプロバイダーとのコミュニケーションの促進など、患者の服薬アドヒアランスをサポートする機能がさらに強化されました。

世界のウェアラブル注射器市場は、在宅ヘルスケアや遠隔医療サービスの拡大という動向の高まりからも恩恵を受けています。ヘルスケアシステムが入院患者を減らし、より身近な場所でケアを提供しようと努力する中、ウェアラブル注射器は遠隔患者管理を可能にする重要な存在になりつつあります。これらの機器により、患者は直接訪問することなく複雑な治療を受けることができ、在宅輸液サービスや遠隔医療ソリューションの需要の高まりを支えています。さらに、慢性疾患や複雑な薬物療法を受けやすい老年人口の増加が、ウェアラブル注射器市場のさらなる成長を促進すると予想されます。技術が進化し続け、ウェアラブル注射器を介して投与される治療法の幅が広がるにつれ、世界市場は、技術革新、患者の需要、進化するヘルスケア慣行のダイナミックな相互作用によって、持続的な成長を遂げる態勢が整っています。

調査対象企業の例（全43件）

  • Amgen, Inc.
  • Becton, Dickinson and Company
  • Bespak Europe Ltd.
  • Enable Injections, Inc.
  • Insulet Corporation
  • Medtronic PLC
  • Sensile Medical AG
  • Tandem Diabetes Care, Inc.
  • United Therapeutics Corporation
  • Valeritas, Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP16900

Global Wearable Injectors Market to Reach US$20.4 Billion by 2030

The global market for Wearable Injectors estimated at US$10.7 Billion in the year 2023, is expected to reach US$20.4 Billion by 2030, growing at a CAGR of 9.6% over the analysis period 2023-2030. On-Body injectors, one of the segments analyzed in the report, is expected to record a 9.4% CAGR and reach US$14.7 Billion by the end of the analysis period. Growth in the Off-Body injectors segment is estimated at 10.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.9 Billion While China is Forecast to Grow at 9.0% CAGR

The Wearable Injectors market in the U.S. is estimated at US$2.9 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$3.2 Billion by the year 2030 trailing a CAGR of 9.0% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.5% and 8.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.5% CAGR.

Global Wearable Injectors Market - Key Trends & Growth Drivers Explored

Why Are Wearable Injectors Revolutionizing the Drug Delivery Landscape?

Wearable injectors have emerged as a groundbreaking innovation in the drug delivery landscape, providing a convenient and patient-friendly alternative to traditional injection methods. But what exactly makes these devices so transformative in modern healthcare? Wearable injectors are compact, user-friendly devices designed to administer large volumes of medication subcutaneously over an extended period, typically ranging from several minutes to several hours. These devices are worn on the patient’s body, allowing for continuous or scheduled drug delivery without the need for repeated manual injections. Wearable injectors are particularly beneficial for administering biologic drugs, such as monoclonal antibodies, hormones, and other high-viscosity formulations that require slow infusion to avoid adverse reactions. They offer a more comfortable and less invasive option for patients, making it easier to adhere to treatment regimens, especially for chronic conditions that require frequent dosing.

The demand for wearable injectors is being driven by the growing prevalence of chronic diseases such as diabetes, autoimmune disorders, and cardiovascular conditions, which require long-term medication management. For many of these conditions, biologics have become the standard of care, but their complex administration can be a barrier to patient adherence. Wearable injectors address this challenge by enabling patients to self-administer medications in a home setting, reducing the need for frequent clinic visits and improving treatment compliance. Additionally, wearable injectors are gaining traction in oncology, where they are used to deliver chemotherapy and supportive care medications in a controlled and comfortable manner. As the pharmaceutical industry continues to develop more biologic therapies, wearable injectors are expected to play an increasingly critical role in delivering these complex drugs, improving patient outcomes and overall quality of life.

How Are Technological Advancements Elevating the Performance of Wearable Injectors?

The wearable injectors market has witnessed significant technological advancements that have enhanced the safety, efficiency, and usability of these devices. But what are the key innovations driving these developments? One of the most notable advancements is the integration of electronic and digital technologies into wearable injectors, enabling precise control over dosing and delivery rates. Modern wearable injectors are equipped with microprocessor-controlled mechanisms that ensure accurate and consistent drug delivery, minimizing the risk of under- or overdosing. These devices can also include pre-programmed dosing schedules, providing flexibility for administering complex treatment regimens. The integration of smart sensors and connectivity features allows wearable injectors to monitor patient adherence and provide real-time feedback through smartphone apps or connected health platforms. This connectivity enables patients and healthcare providers to track dosing history, monitor device performance, and receive alerts if any issues arise during the infusion process.

Another critical innovation is the development of advanced materials and ergonomic designs that enhance the comfort and usability of wearable injectors. These devices are now made from lightweight, biocompatible materials that conform to the body’s contours, making them comfortable to wear for extended periods. Innovations in adhesive technology have improved the device’s ability to remain securely attached to the skin without causing irritation, even during physical activity. The design of wearable injectors has also evolved to include discreet and user-friendly features such as easy-to-activate buttons, visual and audible indicators, and automatic needle insertion and retraction systems. These advancements have reduced the complexity of using wearable injectors, making them more accessible to a broader range of patients, including those with limited dexterity or vision. Furthermore, the development of self-injection training tools and virtual simulations has helped improve patient confidence and proficiency in using these devices, contributing to higher adherence rates and better therapeutic outcomes.

What Market Trends Are Driving the Adoption of Wearable Injectors Across Healthcare Settings?

Several key market trends are shaping the adoption of wearable injectors across various healthcare settings, reflecting the evolving needs and preferences of patients, healthcare providers, and pharmaceutical companies. One of the most prominent trends is the shift towards patient-centric care and self-administration of therapies. With the increasing focus on personalized medicine and home-based healthcare, wearable injectors have become a preferred option for patients who want to manage their treatments in the comfort of their own homes. This trend is particularly strong in the management of chronic diseases, where continuous drug delivery and regular dosing are required. Wearable injectors empower patients by providing them with a convenient, discreet, and reliable means of administering their medications without the need for frequent hospital or clinic visits. This not only enhances the patient experience but also reduces the burden on healthcare facilities, making wearable injectors an attractive option for healthcare systems looking to optimize resource utilization.

Another key trend driving the adoption of wearable injectors is the increasing use of biologic therapies and high-viscosity drugs. Biologics, which include a range of therapeutic proteins, antibodies, and hormones, are often administered in large volumes that cannot be easily delivered using traditional syringes or autoinjectors. Wearable injectors provide a solution for administering these drugs by allowing for the controlled delivery of high-viscosity formulations over an extended period. This has expanded the range of treatments that can be self-administered, making it possible for more patients to receive biologic therapies at home. Additionally, pharmaceutical companies are increasingly collaborating with wearable injector manufacturers to develop combination products that integrate the drug and device into a single, pre-filled unit. These combination products simplify the drug delivery process, enhance patient convenience, and reduce the risk of dosing errors, driving further adoption of wearable injectors. As the market for biologics continues to grow and the need for patient-friendly drug delivery solutions increases, wearable injectors are expected to become a standard component of many therapeutic regimens.

What Factors Are Driving the Growth of the Global Wearable Injectors Market?

The growth in the global wearable injectors market is driven by several factors, including advancements in drug delivery technology, the increasing prevalence of chronic diseases, and the rising adoption of home healthcare. One of the primary growth drivers is the rising demand for biologic therapies, which are used to treat a wide range of conditions, including autoimmune diseases, cancer, and hormonal disorders. Biologic drugs are often administered in high volumes or require prolonged infusion times, making them ideal candidates for delivery via wearable injectors. The expanding pipeline of biologic drugs, coupled with the increasing number of patients receiving these therapies, has created a significant market opportunity for wearable injectors that can deliver these complex drugs safely and effectively. Pharmaceutical companies are increasingly adopting wearable injectors as part of their drug delivery strategies, particularly for therapies that require patient adherence and long-term management.

Another key growth driver is the increasing focus on improving patient adherence and compliance with therapy. Poor adherence to injectable therapies is a major challenge in chronic disease management, leading to suboptimal treatment outcomes and increased healthcare costs. Wearable injectors address this challenge by providing a more convenient and less invasive method of drug delivery, reducing the frequency and discomfort associated with traditional injections. The ability of wearable injectors to deliver drugs over an extended period also reduces the need for multiple injections, making it easier for patients to adhere to their prescribed regimens. The integration of smart technology and connectivity features in wearable injectors has further enhanced their ability to support patient adherence by providing reminders, monitoring dosing history, and facilitating communication with healthcare providers.

The global wearable injectors market is also benefiting from the increasing trend towards home-based healthcare and the expansion of telemedicine services. As healthcare systems strive to reduce hospital admissions and provide care closer to home, wearable injectors are becoming a key enabler of remote patient management. These devices allow patients to receive complex therapies without the need for in-person visits, supporting the growing demand for home infusion services and telehealth solutions. Moreover, the rising geriatric population, which is more susceptible to chronic diseases and complex medication regimens, is expected to drive further growth in the wearable injectors market. As the technology continues to evolve and the range of therapies administered via wearable injectors expands, the global market is poised for sustained growth, driven by a dynamic interplay of innovation, patient demand, and evolving healthcare practices.

Select Competitors (Total 43 Featured) -

  • Amgen, Inc.
  • Becton, Dickinson and Company
  • Bespak Europe Ltd.
  • Enable Injections, Inc.
  • Insulet Corporation
  • Medtronic PLC
  • Sensile Medical AG
  • Tandem Diabetes Care, Inc.
  • United Therapeutics Corporation
  • Valeritas, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Wearable Injectors - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Self-Administration and Home-Based Drug Delivery Solutions Drives Growth of Wearable Injectors Market
    • Increased Adoption of Wearable Injectors in Chronic Disease Management Expands Addressable Market
    • Surge in Demand for Wearable Injectors in Diabetes and Insulin Delivery Fuels Market Growth
    • Rising Adoption of Wearable Injectors in Oncology and Biologic Drug Delivery Sets the Stage for Market Growth
    • Surge in Use of Wearable Injectors in Hormone and Pain Management Therapies Expands Market Opportunities
    • Technological Innovations in Micro-Needle and Patch-Based Wearable Injectors Propel Market Growth
    • Increased Utilization of Wearable Injectors in Rheumatology and Immunology Drug Delivery Fuels Market Demand
    • Rising Focus on Reducing Hospital Visits and Healthcare Costs Drives Adoption of Wearable Injectors
    • Surge in Demand for Wearable Injectors in Cardiology and Endocrinology Applications Expands Market Opportunities
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Wearable Injectors Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Wearable Injectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World 7-Year Perspective for Wearable Injectors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for On-Body injectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World 7-Year Perspective for On-Body injectors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Off-Body injectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 7: World 7-Year Perspective for Off-Body injectors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Immuno-oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World 7-Year Perspective for Immuno-oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World 7-Year Perspective for Diabetes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Other Therapies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 13: World 7-Year Perspective for Other Therapies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Spring Based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World 7-Year Perspective for Spring Based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Motor Driven by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 17: World 7-Year Perspective for Motor Driven by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Rotary Pump by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 19: World 7-Year Perspective for Rotary Pump by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Battery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World 7-Year Perspective for Battery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 23: World 7-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Semi-Reusable by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 25: World 7-Year Perspective for Semi-Reusable by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Disposable by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: World 7-Year Perspective for Disposable by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Wearable Injectors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 28: USA Recent Past, Current & Future Analysis for Wearable Injectors by Type - On-Body injectors and Off-Body injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 29: USA 7-Year Perspective for Wearable Injectors by Type - Percentage Breakdown of Value Sales for On-Body injectors and Off-Body injectors for the Years 2024 & 2030
    • TABLE 30: USA Recent Past, Current & Future Analysis for Wearable Injectors by Therapy - Immuno-oncology, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 31: USA 7-Year Perspective for Wearable Injectors by Therapy - Percentage Breakdown of Value Sales for Immuno-oncology, Diabetes and Other Therapies for the Years 2024 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Wearable Injectors by Technology - Spring Based, Motor Driven, Rotary Pump, Battery and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA 7-Year Perspective for Wearable Injectors by Technology - Percentage Breakdown of Value Sales for Spring Based, Motor Driven, Rotary Pump, Battery and Other Technologies for the Years 2024 & 2030
    • TABLE 34: USA Recent Past, Current & Future Analysis for Wearable Injectors by Usage - Semi-Reusable and Disposable - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 35: USA 7-Year Perspective for Wearable Injectors by Usage - Percentage Breakdown of Value Sales for Semi-Reusable and Disposable for the Years 2024 & 2030
  • CANADA
    • TABLE 36: Canada Recent Past, Current & Future Analysis for Wearable Injectors by Type - On-Body injectors and Off-Body injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 37: Canada 7-Year Perspective for Wearable Injectors by Type - Percentage Breakdown of Value Sales for On-Body injectors and Off-Body injectors for the Years 2024 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Wearable Injectors by Therapy - Immuno-oncology, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada 7-Year Perspective for Wearable Injectors by Therapy - Percentage Breakdown of Value Sales for Immuno-oncology, Diabetes and Other Therapies for the Years 2024 & 2030
    • TABLE 40: Canada Recent Past, Current & Future Analysis for Wearable Injectors by Technology - Spring Based, Motor Driven, Rotary Pump, Battery and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 41: Canada 7-Year Perspective for Wearable Injectors by Technology - Percentage Breakdown of Value Sales for Spring Based, Motor Driven, Rotary Pump, Battery and Other Technologies for the Years 2024 & 2030
    • TABLE 42: Canada Recent Past, Current & Future Analysis for Wearable Injectors by Usage - Semi-Reusable and Disposable - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 43: Canada 7-Year Perspective for Wearable Injectors by Usage - Percentage Breakdown of Value Sales for Semi-Reusable and Disposable for the Years 2024 & 2030
  • JAPAN
    • Wearable Injectors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Wearable Injectors by Type - On-Body injectors and Off-Body injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Japan 7-Year Perspective for Wearable Injectors by Type - Percentage Breakdown of Value Sales for On-Body injectors and Off-Body injectors for the Years 2024 & 2030
    • TABLE 46: Japan Recent Past, Current & Future Analysis for Wearable Injectors by Therapy - Immuno-oncology, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 47: Japan 7-Year Perspective for Wearable Injectors by Therapy - Percentage Breakdown of Value Sales for Immuno-oncology, Diabetes and Other Therapies for the Years 2024 & 2030
    • TABLE 48: Japan Recent Past, Current & Future Analysis for Wearable Injectors by Technology - Spring Based, Motor Driven, Rotary Pump, Battery and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 49: Japan 7-Year Perspective for Wearable Injectors by Technology - Percentage Breakdown of Value Sales for Spring Based, Motor Driven, Rotary Pump, Battery and Other Technologies for the Years 2024 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Wearable Injectors by Usage - Semi-Reusable and Disposable - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Japan 7-Year Perspective for Wearable Injectors by Usage - Percentage Breakdown of Value Sales for Semi-Reusable and Disposable for the Years 2024 & 2030
  • CHINA
    • Wearable Injectors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 52: China Recent Past, Current & Future Analysis for Wearable Injectors by Type - On-Body injectors and Off-Body injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 53: China 7-Year Perspective for Wearable Injectors by Type - Percentage Breakdown of Value Sales for On-Body injectors and Off-Body injectors for the Years 2024 & 2030
    • TABLE 54: China Recent Past, Current & Future Analysis for Wearable Injectors by Therapy - Immuno-oncology, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 55: China 7-Year Perspective for Wearable Injectors by Therapy - Percentage Breakdown of Value Sales for Immuno-oncology, Diabetes and Other Therapies for the Years 2024 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Wearable Injectors by Technology - Spring Based, Motor Driven, Rotary Pump, Battery and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: China 7-Year Perspective for Wearable Injectors by Technology - Percentage Breakdown of Value Sales for Spring Based, Motor Driven, Rotary Pump, Battery and Other Technologies for the Years 2024 & 2030
    • TABLE 58: China Recent Past, Current & Future Analysis for Wearable Injectors by Usage - Semi-Reusable and Disposable - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 59: China 7-Year Perspective for Wearable Injectors by Usage - Percentage Breakdown of Value Sales for Semi-Reusable and Disposable for the Years 2024 & 2030
  • EUROPE
    • Wearable Injectors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 60: Europe Recent Past, Current & Future Analysis for Wearable Injectors by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 61: Europe 7-Year Perspective for Wearable Injectors by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Wearable Injectors by Type - On-Body injectors and Off-Body injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Europe 7-Year Perspective for Wearable Injectors by Type - Percentage Breakdown of Value Sales for On-Body injectors and Off-Body injectors for the Years 2024 & 2030
    • TABLE 64: Europe Recent Past, Current & Future Analysis for Wearable Injectors by Therapy - Immuno-oncology, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 65: Europe 7-Year Perspective for Wearable Injectors by Therapy - Percentage Breakdown of Value Sales for Immuno-oncology, Diabetes and Other Therapies for the Years 2024 & 2030
    • TABLE 66: Europe Recent Past, Current & Future Analysis for Wearable Injectors by Technology - Spring Based, Motor Driven, Rotary Pump, Battery and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 67: Europe 7-Year Perspective for Wearable Injectors by Technology - Percentage Breakdown of Value Sales for Spring Based, Motor Driven, Rotary Pump, Battery and Other Technologies for the Years 2024 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Wearable Injectors by Usage - Semi-Reusable and Disposable - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Europe 7-Year Perspective for Wearable Injectors by Usage - Percentage Breakdown of Value Sales for Semi-Reusable and Disposable for the Years 2024 & 2030
  • FRANCE
    • Wearable Injectors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 70: France Recent Past, Current & Future Analysis for Wearable Injectors by Type - On-Body injectors and Off-Body injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 71: France 7-Year Perspective for Wearable Injectors by Type - Percentage Breakdown of Value Sales for On-Body injectors and Off-Body injectors for the Years 2024 & 2030
    • TABLE 72: France Recent Past, Current & Future Analysis for Wearable Injectors by Therapy - Immuno-oncology, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 73: France 7-Year Perspective for Wearable Injectors by Therapy - Percentage Breakdown of Value Sales for Immuno-oncology, Diabetes and Other Therapies for the Years 2024 & 2030
    • TABLE 74: France Recent Past, Current & Future Analysis for Wearable Injectors by Technology - Spring Based, Motor Driven, Rotary Pump, Battery and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: France 7-Year Perspective for Wearable Injectors by Technology - Percentage Breakdown of Value Sales for Spring Based, Motor Driven, Rotary Pump, Battery and Other Technologies for the Years 2024 & 2030
    • TABLE 76: France Recent Past, Current & Future Analysis for Wearable Injectors by Usage - Semi-Reusable and Disposable - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 77: France 7-Year Perspective for Wearable Injectors by Usage - Percentage Breakdown of Value Sales for Semi-Reusable and Disposable for the Years 2024 & 2030
  • GERMANY
    • Wearable Injectors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 78: Germany Recent Past, Current & Future Analysis for Wearable Injectors by Type - On-Body injectors and Off-Body injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 79: Germany 7-Year Perspective for Wearable Injectors by Type - Percentage Breakdown of Value Sales for On-Body injectors and Off-Body injectors for the Years 2024 & 2030
    • TABLE 80: Germany Recent Past, Current & Future Analysis for Wearable Injectors by Therapy - Immuno-oncology, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Germany 7-Year Perspective for Wearable Injectors by Therapy - Percentage Breakdown of Value Sales for Immuno-oncology, Diabetes and Other Therapies for the Years 2024 & 2030
    • TABLE 82: Germany Recent Past, Current & Future Analysis for Wearable Injectors by Technology - Spring Based, Motor Driven, Rotary Pump, Battery and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 83: Germany 7-Year Perspective for Wearable Injectors by Technology - Percentage Breakdown of Value Sales for Spring Based, Motor Driven, Rotary Pump, Battery and Other Technologies for the Years 2024 & 2030
    • TABLE 84: Germany Recent Past, Current & Future Analysis for Wearable Injectors by Usage - Semi-Reusable and Disposable - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 85: Germany 7-Year Perspective for Wearable Injectors by Usage - Percentage Breakdown of Value Sales for Semi-Reusable and Disposable for the Years 2024 & 2030
  • ITALY
    • TABLE 86: Italy Recent Past, Current & Future Analysis for Wearable Injectors by Type - On-Body injectors and Off-Body injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Italy 7-Year Perspective for Wearable Injectors by Type - Percentage Breakdown of Value Sales for On-Body injectors and Off-Body injectors for the Years 2024 & 2030
    • TABLE 88: Italy Recent Past, Current & Future Analysis for Wearable Injectors by Therapy - Immuno-oncology, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 89: Italy 7-Year Perspective for Wearable Injectors by Therapy - Percentage Breakdown of Value Sales for Immuno-oncology, Diabetes and Other Therapies for the Years 2024 & 2030
    • TABLE 90: Italy Recent Past, Current & Future Analysis for Wearable Injectors by Technology - Spring Based, Motor Driven, Rotary Pump, Battery and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 91: Italy 7-Year Perspective for Wearable Injectors by Technology - Percentage Breakdown of Value Sales for Spring Based, Motor Driven, Rotary Pump, Battery and Other Technologies for the Years 2024 & 2030
    • TABLE 92: Italy Recent Past, Current & Future Analysis for Wearable Injectors by Usage - Semi-Reusable and Disposable - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Italy 7-Year Perspective for Wearable Injectors by Usage - Percentage Breakdown of Value Sales for Semi-Reusable and Disposable for the Years 2024 & 2030
  • UNITED KINGDOM
    • Wearable Injectors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 94: UK Recent Past, Current & Future Analysis for Wearable Injectors by Type - On-Body injectors and Off-Body injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 95: UK 7-Year Perspective for Wearable Injectors by Type - Percentage Breakdown of Value Sales for On-Body injectors and Off-Body injectors for the Years 2024 & 2030
    • TABLE 96: UK Recent Past, Current & Future Analysis for Wearable Injectors by Therapy - Immuno-oncology, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 97: UK 7-Year Perspective for Wearable Injectors by Therapy - Percentage Breakdown of Value Sales for Immuno-oncology, Diabetes and Other Therapies for the Years 2024 & 2030
    • TABLE 98: UK Recent Past, Current & Future Analysis for Wearable Injectors by Technology - Spring Based, Motor Driven, Rotary Pump, Battery and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: UK 7-Year Perspective for Wearable Injectors by Technology - Percentage Breakdown of Value Sales for Spring Based, Motor Driven, Rotary Pump, Battery and Other Technologies for the Years 2024 & 2030
    • TABLE 100: UK Recent Past, Current & Future Analysis for Wearable Injectors by Usage - Semi-Reusable and Disposable - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 101: UK 7-Year Perspective for Wearable Injectors by Usage - Percentage Breakdown of Value Sales for Semi-Reusable and Disposable for the Years 2024 & 2030
  • REST OF EUROPE
    • TABLE 102: Rest of Europe Recent Past, Current & Future Analysis for Wearable Injectors by Type - On-Body injectors and Off-Body injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 103: Rest of Europe 7-Year Perspective for Wearable Injectors by Type - Percentage Breakdown of Value Sales for On-Body injectors and Off-Body injectors for the Years 2024 & 2030
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Wearable Injectors by Therapy - Immuno-oncology, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Rest of Europe 7-Year Perspective for Wearable Injectors by Therapy - Percentage Breakdown of Value Sales for Immuno-oncology, Diabetes and Other Therapies for the Years 2024 & 2030
    • TABLE 106: Rest of Europe Recent Past, Current & Future Analysis for Wearable Injectors by Technology - Spring Based, Motor Driven, Rotary Pump, Battery and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 107: Rest of Europe 7-Year Perspective for Wearable Injectors by Technology - Percentage Breakdown of Value Sales for Spring Based, Motor Driven, Rotary Pump, Battery and Other Technologies for the Years 2024 & 2030
    • TABLE 108: Rest of Europe Recent Past, Current & Future Analysis for Wearable Injectors by Usage - Semi-Reusable and Disposable - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 109: Rest of Europe 7-Year Perspective for Wearable Injectors by Usage - Percentage Breakdown of Value Sales for Semi-Reusable and Disposable for the Years 2024 & 2030
  • ASIA-PACIFIC
    • Wearable Injectors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Wearable Injectors by Type - On-Body injectors and Off-Body injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific 7-Year Perspective for Wearable Injectors by Type - Percentage Breakdown of Value Sales for On-Body injectors and Off-Body injectors for the Years 2024 & 2030
    • TABLE 112: Asia-Pacific Recent Past, Current & Future Analysis for Wearable Injectors by Therapy - Immuno-oncology, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 113: Asia-Pacific 7-Year Perspective for Wearable Injectors by Therapy - Percentage Breakdown of Value Sales for Immuno-oncology, Diabetes and Other Therapies for the Years 2024 & 2030
    • TABLE 114: Asia-Pacific Recent Past, Current & Future Analysis for Wearable Injectors by Technology - Spring Based, Motor Driven, Rotary Pump, Battery and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 115: Asia-Pacific 7-Year Perspective for Wearable Injectors by Technology - Percentage Breakdown of Value Sales for Spring Based, Motor Driven, Rotary Pump, Battery and Other Technologies for the Years 2024 & 2030
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Wearable Injectors by Usage - Semi-Reusable and Disposable - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific 7-Year Perspective for Wearable Injectors by Usage - Percentage Breakdown of Value Sales for Semi-Reusable and Disposable for the Years 2024 & 2030
  • REST OF WORLD
    • TABLE 118: Rest of World Recent Past, Current & Future Analysis for Wearable Injectors by Type - On-Body injectors and Off-Body injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 119: Rest of World 7-Year Perspective for Wearable Injectors by Type - Percentage Breakdown of Value Sales for On-Body injectors and Off-Body injectors for the Years 2024 & 2030
    • TABLE 120: Rest of World Recent Past, Current & Future Analysis for Wearable Injectors by Therapy - Immuno-oncology, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 121: Rest of World 7-Year Perspective for Wearable Injectors by Therapy - Percentage Breakdown of Value Sales for Immuno-oncology, Diabetes and Other Therapies for the Years 2024 & 2030
    • TABLE 122: Rest of World Recent Past, Current & Future Analysis for Wearable Injectors by Technology - Spring Based, Motor Driven, Rotary Pump, Battery and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Rest of World 7-Year Perspective for Wearable Injectors by Technology - Percentage Breakdown of Value Sales for Spring Based, Motor Driven, Rotary Pump, Battery and Other Technologies for the Years 2024 & 2030
    • TABLE 124: Rest of World Recent Past, Current & Future Analysis for Wearable Injectors by Usage - Semi-Reusable and Disposable - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 125: Rest of World 7-Year Perspective for Wearable Injectors by Usage - Percentage Breakdown of Value Sales for Semi-Reusable and Disposable for the Years 2024 & 2030

IV. COMPETITION